Clinical Trial Update: Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and efficacy of panobinostat plus bicalutamide in recurrent prostate cancer after castration (Phase 1/2, completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Panobinostat (Panobinostat)
• bicalutamide (bicalutamide)

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer, Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-12-04